Eisai
4523.T
#2182
Rank
HK$65.94 B
Marketcap
HK$233.74
Share price
0.34%
Change (1 day)
2.72%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of September 2025 : HK$12.44 Billion

According to Eisai's latest financial reports the company's total debt is HK$12.44 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2025-03-31HK$9.73 B18.11%
2024-03-31HK$8.23 B10.99%
2023-03-31HK$7.42 B21.59%
2022-03-31HK$6.10 B-3.25%
2021-03-31HK$6.31 B-2.69%
2020-03-31HK$6.48 B-33.98%
2019-03-31HK$9.82 B-23.15%
2018-03-31HK$12.78 B-14.27%
2017-03-31HK$14.90 B6.21%
2016-03-31HK$14.03 B-7.94%
2015-03-31HK$15.24 B-17.92%
2014-03-31HK$18.57 B-28.14%
2013-03-31HK$25.85 B-20.08%
2012-03-31HK$32.35 B-8.72%
2011-03-31HK$35.44 B4.52%
2010-03-31HK$33.91 B2.38%
2009-03-31HK$33.12 B5.23%
2008-03-31HK$31.47 B200935.89%
2007-03-31HK$15.65 M-42.68%
2006-03-31HK$27.31 M-54.77%
2005-03-31HK$60.38 M321.29%
2004-03-31HK$14.33 M518.52%
2003-03-31HK$2.31 M-99.39%
2002-03-31HK$0.38 B-21.55%
2001-03-31HK$0.48 B-63.62%
2000-03-31HK$1.34 B